Effectiveness of Mobile Respiratory Training in Ankylosing Spondylitis
Effectiveness of Respiratory Muscle Training Using a Mobile Respiratory Trainer in People With Ankylosing Spondylitis
2 other identifiers
interventional
80
1 country
1
Brief Summary
Introduction and aim; Low functionality of respiratory muscles is frequently observed in various diseases such as chronic obstructive pulmonary disease, cystic fibrosis, idiopathic pulmonary fibrosis, and rheumatological diseases such as ankylosing spondylitis. Strengthening the respiratory muscles is a part of the treatment in such disease groups, and it has been reported that the quality of life of patients increases with the improvement in the respiratory muscles. Stavrou et al. In a study published in 2021, they achieved an increase in VO2max and maximum respiratory power in athletes after an exercise program with the AirOFit PRO™ (AirOFit, Copenhagen, Denmark) branded mobile breathing exercise device, which they introduced as a new technology. However, there is no study yet reporting the use of this device in rheumatological diseases. The aim of this study is to investigate the effects of personalized breathing exercises with the AirOFit PRO™ (AirOFit, Copenhagen, Denmark) branded mobile breathing exercise device on respiratory muscles and functional exercise capacity, as well as on specific outcomes of the disease, in patients with ankylosing spondylitis. Hypotheses of the study; a) Hypothesis H1: Personalised breathing exercises applied with a mobile respiratory exercise device in patients with ankylosing spondylitis have a positive effect on respiratory capacity and activities of daily living in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 18, 2024
CompletedFirst Posted
Study publicly available on registry
October 22, 2024
CompletedStudy Start
First participant enrolled
November 5, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
May 22, 2025
CompletedJuly 8, 2025
July 1, 2025
6 months
October 18, 2024
July 4, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Tidal volume
Tidal volume; This is the amount of air breathed in or out during normal breathing. This pulmonary function test will done with a spirometry.
At the end of the 12th week of exercise schedule
Vital capacity
This is the total volume of air that can be breathed out after breathing in as much as you can. This pulmonary function test will done with a spirometry.
At the end of the 12th week of exercise schedule
Forced vital capacity
Forced vital capacity (FVC); This is the amount of air breathed out forcefully and quickly after breathing in as much as you can. This pulmonary function test will done with a spirometry.
At the end of the 12th week of exercise schedule
Secondary Outcomes (1)
The Bath Ankylosing Spondylitis Functional Index
At the end of the 12th week of exercise schedule
Study Arms (2)
Exercisers with a mobile breathing apparatus
ACTIVE COMPARATORThe mobile device will be given to the patient for use. The exercise programme will be taught by the physiotherapist with face-to-face training before the study. The settings of the device will be started at the beginner level in breathing and exhalation exercises.
Pursed Lip Breathing Exercisers
ACTIVE COMPARATOR'Pursed lip breathing' will be taught to the patients in this group. The programme will be taught by the physiotherapist with face-to-face training before the study. The patient will be taught to take a deep breath through the nose as much as he/she can and then to empty the air in the lungs in a controlled manner without applying any force by pursing the lips as if whistling.
Interventions
Patients were planned to complete exercise sessions 5 times a week for 12 weeks, each lasting 35 minutes per day.
Patients were planned to complete exercise sessions 5 times a week for 12 weeks, each lasting 35 minutes per day.
Eligibility Criteria
You may qualify if:
- Volunteer for the study
- Be over 18 years old
- To be in the follow-up of Usak University Rheumatology outpatient clinic
- Stability in medical treatment (keeping disease activity under control with the same medical treatment for at least 6 months)
You may not qualify if:
- The presence of diseases that affect the function of the respiratory system (such as pneumonia, pleurisy, empyema, pneumothorax, hemothorax, hydrothorax, atelectasis, pulmonary oedema, pulmonary hypertension, emphysema, and lung cancer).
- The presence of a regular exercise habit (regularly 3 days a week for at least six months).
- Significant physical disability or impairment (regular use of walking aids, etc.)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uşak Universitylead
Study Sites (1)
Usak University
Uşak, 64200, Turkey (Türkiye)
Related Publications (1)
Stavrou VT, Tourlakopoulos KN, Daniil Z, Gourgoulianis KI. Respiratory Muscle Strength: New Technology for Easy Assessment. Cureus. 2021 May 2;13(5):e14803. doi: 10.7759/cureus.14803.
PMID: 34094759RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ali Y KARAHAN, MD
Uşak University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- A blind physiotherapist will be in charge of the assessment of the outcomes of the study in all patients.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 18, 2024
First Posted
October 22, 2024
Study Start
November 5, 2024
Primary Completion
May 12, 2025
Study Completion
May 22, 2025
Last Updated
July 8, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
Sharing personal data must comply with the data protection principles in Turkey.